Gene therapy developer bluebird bio to cut 30% of staff
April 05, 2022 at 12:14 PM EDT
The company said Tuesday morning that the layoffs are part of a restructuring intended to save as much as $160 million over the next two years.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|